Kuano London
About Kuano London
Kuano uses quantum simulation and quantum-inspired AI for enzyme drug design with programs in epigenetics, protein degradation, and infectious disease. The London company develops quantum-enhanced drug discovery platforms. Kuano combines quantum algorithms with machine learning to accelerate enzyme engineering and drug design, targeting challenging therapeutic areas where conventional computational methods provide limited insights.
2025 Developments: The company continues its quantum technology initiatives throughout 2025. Focus remains on advancing core technologies and expanding market presence. Ongoing development activities position the company for future growth in the quantum industry.
Company Information
- Founded: 2020
- Country: United Kingdom
- Website: https://kuano.ai
- Categories: quantum chemistry, drug discovery
Related Companies
Explore other quantum computing companies in similar categories or regions.